SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
Completed
Conditions studied: Overweight, Obesity
In brief
Participants are being asked to participate in SELECT-LIFE study because participants take part in the SELECT trial. SELECT-LIFE study is a survey-based study that will start when the SELECT trial ends. SELECT-LIFE looks at the long-term effects of participants taking part in the SELECT trial including the trial medicine participants have been taking. When the SELECT trial ends, participants will no longer get the medicine participants got in the study, even if participants decide to take part in the SELECT-LIFE study. Participants will not get any specific treatment or medicine as part of the SELECT-LIFE study, and participants will be treated as participants normally would by their own doctor. The SELECT-LIFE study will last for up to 10 years after SELECT trial ends, and participants will be asked to fill in a questionnaire about their health every 6 months.
Key facts
- Study ID
- NCT04972721
- Run by
- Novo Nordisk A/S
- People needed
- 3439
- Starts
- 2023-09-01
- Expected to finish
- 2025-08-25
- Last updated by the study team
- 2026-02-11
Who can join
Age: 45 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Randomized into the SELECT clinical trial (EX9536-4388) and has not withdrawn consent, regardless of level of participation, dose achieved or treatment discontinuation.
- Signed SELECT-LIFE consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
You may not qualify if…
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Where it is running
- Master Centre for USA — Plainsboro, New Jersey, United States
- Master Centre for Algeria — Algiers, Algeria
- Master Centre for Argentina — Prov. de Buenos Aires, Argentina
- Master Centre for Australia — North Sydney, New South Wales, Australia
- Cárdio Pulmonar da Bahia — Salvador, Estado de Bahia, Brazil
- Hospital do Coração do Brasil — Brasília, Federal District, Brazil
- Eurolatino Medical Research Center — Uberlândia, Minas Gerais, Brazil
- Núcleo de Pesquisa Clínica S/S — Curitiba, Paraná, Brazil
- Hospital São Vicente de Paulo — Passo Fundo, Rio Grande do Sul, Brazil
- AngioCor Blumenau — Blumenau, Santa Catarina, Brazil
- Instituto de Pesquisa Clínica de Campinas — Campinas, São Paulo, Brazil
- CIP Centro Integrado de Pesquisas do Hospital de Base — São José do Rio Preto, São Paulo, Brazil
- CPQuali Pesquisa Clínica Ltda — São Paulo, São Paulo, Brazil
- CPCLIN - Centro de Pesquisas Clínicas — São Paulo, São Paulo, Brazil
- Instituto Dante Pazzanese de Cardiologia — São Paulo, São Paulo, Brazil
- Departamento de Gastroenterologia - HCFMUSP — São Paulo, São Paulo, Brazil
- Instituto do Coração - HCFMUSP — São Paulo, São Paulo, Brazil
- Master Centre for Brazil — Säo Paulo, São Paulo, Brazil
- Instituto Brasil de Pesquisa Clinica — Rio de Janeiro, Brazil
- Master Centre for Canada — Mississauga, Ontario, Canada
- Novo Nordisk Croatia Ltd. — Zagreb, Croatia
- Master Centre for Denmark — Copenhagen S, Denmark
- Master Centre for Finland — Espoo, Finland
- Master Centre for Germany PMS — Mainz, Germany
- Master Centre for Greece — Vouliagment, Greece
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.